6[4]Klauber N, Rohan RM, Flynn E, et al. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470. Nature Med, 1997,3:443 ～ 446.
7[5]Hear G. Therapeutic ultrasound. EurJ Ultrasound,1999,29:3～9.
8[8]Macdonald NJ, Jolesz FA, Hynynen KH. Determination of the optimal delay between sonications during focused ultrasound surgery in rabbit by using MR imagine to monitor thermal buildup in vivo. Radiology, 1999,211:419 ～426.
3Hutchins FL. Abdominal myomectomy as a treatment for symp- tomatic uterine fibroids. Obstetrics and Gynecology Clinics of North America, 1995, 22(4): 781-789.
4Davies A, Hart R, Magos A, et al. Hysterectomy: surgical route and complications. Eur J Obstet Gynecol Reprod Biol, 2002, 04(2): 148- 151.
5Kim Y, Bae DS, Kim BG, et al. A faster nonsurgical solution: very large fibroid tumors yielded to a new ablation strategy. Am J Obstet Gynecol, 2011,205(3): 292-295.
6Walker WJ, Pelage JP. Uterine artery embolisation for symptomatic fibroids: clinical results in 400 women with imaging follow up. BJOG, 2002, 109(11): 1262-1272.
7盂欣.高强度聚焦超声与射频联合治疗富血供的子宫肌瘤的临床研究.第四军医大学,2010.
8Ghezzi F, Cromi A, Bergamini V, et al. Midterm outcome of radi- ofrequency thermal ablation for symptomatic uterine myomas. Surg Endosc, 2007, 21(11): 2081-2085.
9Nevadunsky NS, Bachmann GA, Nosher J, et al. Women's decision- making determinants in choosing uterine artery embolization for symptomatic fibroids.J Reprod Med, 2001, 46( 10): 870-874.
